Description

DISCLAIMER This is an information request only. This request is issued solely for information and planning purposes – it does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. Solicitations are not available currently. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever. Purpose: Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND) invites you to collaborate with us in a critical mission: to develop the next generation of host-based assays for diagnosis of disease etiology, prognostication of clinical outcomes, and directed administration of therapeutic treatments that will protect the warfighter from chemical, biological, radiological, and nuclear (CBRN) threats. This RFI is your opportunity to help shape the future of military medicine and contribute directly to the readiness and resilience of our armed forces. The decade-long surge in tracking host responses to pathogens has spawned diagnostic technologies that utilize specific panels of host response molecules to differentially diagnose the class of pathogen (e.g., bacterial or viral), predict the likelihood of severe illness and/or enable the selection of therapeutic regimen. The goal is to identify and develop a new generation of host-based test to diagnose a warfighter's condition, predict clinical outcomes, and direct the optimum therapeutics for maximal disease recovery. This creates a prime opportunity for innovative companies to align their research and development pipelines with a forward-looking program. Disclaimer: This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government, nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issue because of this RFI Requested Information of Interest: CPE CBRND is conducting essential market research for the Advanced Differential Diagnostics (ADD) program, an existing Program of Record that is developing new diagnostic capabilities in a phased approach. This program is dedicated to identifying and advancing mature diagnostics that utilize the warfighter's early response to the pathogen. CPE CBRN will be focused on developing and delivering diagnostics that help meet operational and mission needs across the conflict continuum. The goal is to create a resilient force, capable of withstanding, mitigating, and recovering from the complex injuries caused by CBRN threats, some of which are outlined in the Medical Management of Biologic Casualties Handbook, Medical Consequences of Radiological and Nuclear Warfare, and Medical Aspects of Chemical Warfare. We are seeking information from industry partners developing innovative solutions that diagnose infection based on measures of the body's response rather than targeting specific pathogens. These tests will rely on host …

Place of Performance

Contracting Office

Contacts